Mark A. Kronenfeld
CIK 1578074 · View on SEC EDGAR ↗
Insider
First SEC filing: Sept. 13, 2013 · Latest: Sept. 13, 2013
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 26 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
26 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 8, 2023 | PCRX | S 10b5-1 | 15,000 | $37.04 | $555,600 | 17,897 Direct | -45.60% | Disposed | -35.0% (price as of 2026-08-20) |
| March 6, 2019 | PCRX | P | 1,000 | $39.14 | $39,140 | 10,277 Direct | +10.78% | Acquired | -38.5% (price as of 2026-08-20) |
| March 6, 2019 | PCRX | P | 700 | $38.72 | $27,104 | 9,277 Direct | +8.16% | Acquired | -37.8% (price as of 2026-08-20) |
| Aug. 28, 2018 | PCRX | P | 1,000 | $44.61 | $44,610 | 8,577 Direct | +13.20% | Acquired | -46.0% (price as of 2026-08-20) |
| Nov. 10, 2017 | PCRX | P | 1,000 | $41.60 | $41,600 | 6,795 Direct | +17.26% | Acquired | -42.1% (price as of 2026-08-20) |
| June 6, 2016 | PCRX | S 10b5-1 | 900 | $46.95 | $42,255 | 2,950 Direct | -23.38% | Disposed | -48.7% (price as of 2026-08-20) |
| Nov. 3, 2014 | PCRX | P | 850 | $90.48 | $76,908 | 1,850 Direct | +85.00% | Acquired | -73.4% (price as of 2026-08-20) |
| Sept. 11, 2013 | PCRX | P | 1,000 | $37.01 | $37,010 | 1,000 Direct | — | Acquired | -34.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 11, 2025 | PCRX | Stock Option (Right to Buy) | Common Stock (11,279) | $24.34 | June 11, 2035 | 11,279 | Acquired |
| June 12, 2024 | PCRX | Stock Option (Right to Buy) | Common Stock (12,179) | $28.68 | June 12, 2034 | 12,179 | Acquired |
| June 14, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (12,925) | $38.74 | June 14, 2033 | 12,925 | Acquired |
| June 8, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $29.90 | June 11, 2023 | 15,000 | Disposed |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (8,225) | $59.39 | June 8, 2032 | 8,225 | Acquired |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (7,626) | $60.96 | June 9, 2031 | 7,626 | Acquired |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (8,027) | $47.65 | June 9, 2030 | 8,027 | Acquired |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (8,437) | $43.54 | June 5, 2029 | 8,437 | Acquired |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (4,693) | $38.35 | June 13, 2028 | 4,693 | Acquired |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (2,714) | $44.20 | June 14, 2027 | 2,714 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (2,975) | $40.34 | June 15, 2026 | 2,975 | Acquired |
| June 3, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (4,000) | $79.43 | June 3, 2025 | 4,000 | Acquired |
| June 3, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (8,000) | $81.00 | June 3, 2024 | 8,000 | Acquired |
| June 12, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $29.20 | June 11, 2023 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).